Literature DB >> 306406

Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice.

H Cantor, L McVay-Boudreau, J Hugenberger, K Naidorf, F W Shen, R K Gershon.   

Abstract

We have shown that (a) purified T-helper cells induce cells of another T-cell set-, expressing the Ly123+Qa1+ surface phenotype, to exert potent suppressive activity, (b) this T-T interaction plays an important role in regulating in vivo immune responses, and (c) this interaction represents an important barrier to protocols intended to augment the immune status of individuals by adoptive (or active) immunotherapy. Our results also indicate that the Ly123+ T-cell set mediating feedback suppression in vivo is sensitive to both low doses of cyclophosphamide and removal of the thymus in adult life. The importance of this T-T interaction to normal, physiologic regulation of the immune system is emphasized by the finding that the major T-cell deficit of NZB mice (an inbred strain of mice that spontaneously develops an autoimmune disorder) is the absence or malfunction of an Ly123+ T-cell set responsible for feedback inhibition.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 306406      PMCID: PMC2184249          DOI: 10.1084/jem.147.4.1116

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Regulation of the immune response by subclasses of T lymphocytes. II. The effect of adult thymectomy upon humoral and cellular responses in mice.

Authors:  E Simpson; H Cantor
Journal:  Eur J Immunol       Date:  1975-05       Impact factor: 5.532

2.  Selective loss of suppressor cell function in New Zealand mice induced by NTA.

Authors:  L W Klassen; R S Krakauer; A D Steinberg
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  Lymphocytes as models for the study of mammalian cellular differentiation.

Authors:  H Cantor; E A Boyse
Journal:  Immunol Rev       Date:  1977-01       Impact factor: 12.988

4.  Genesis of antinuclear antibody in NZB-W mice: role of genetic factors and of viral infections.

Authors:  P H Lambert; F J Dixon
Journal:  Clin Exp Immunol       Date:  1970-06       Impact factor: 4.330

5.  The appearance of immunological competence at an early age in New Zealand black mice.

Authors:  M M Evans; W G Williamson; W J Irvine
Journal:  Clin Exp Immunol       Date:  1968-06       Impact factor: 4.330

6.  Maintenance of hyporesponsiveness to antigen by a distinct subclass of T lymphocytes.

Authors:  S Weitzman; F W Shen; H Cantor
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

7.  Independent differentiative pathways of Ly1 and Ly23 subclasses of T cells. Experimental production of mice deprived of selected T-cell subclasses.

Authors:  B Huber; H Cantor; F W Shen; E A Boyse
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

8.  Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition.

Authors:  D D Eardley; J Hugenberger; L McVay-Boudreau; F W Shen; R K Gershon; H Cantor
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

9.  Identification of a cell-surface antigen selectively expressed on the natural killer cell.

Authors:  L Glimcher; F W Shen; H Cantor
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

10.  Induction of immunologic tolerance in older New Zealand mice repopulated with young spleen, bone marrow, or thymus.

Authors:  P J Staples; A D Steinberg; N Talal
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

View more
  89 in total

Review 1.  Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells.

Authors:  M Vukmanovic-Stejic; M J Thomas; A Noble; D M Kemeny
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

2.  Abnormalities in clonable B lymphocytes and myeloid progenitors in autoimmune NZB mice.

Authors:  P W Kincade; G Lee; G Fernandes; M A Moore; N Williams; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

3.  Induction of suppressor activity in the autologous mixed lymphocyte reaction and in cultures with concanavalin A.

Authors:  J B Innes; M M Kuntz; Y T Kim; M E Weksler
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

4.  Alterations of the immune response associated with chronic experimental leishmaniasis.

Authors:  B Arredondo; H Pérez
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

5.  Analysis of B-cell abnormalities in autoimmune mice by in vitro culture system using two types of bone marrow stromal cell clone.

Authors:  J Ohmori; T Ezaki; M Kotani
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

6.  An IgG subclass imbalance in connective tissue disease.

Authors:  R A Kay; K J Wood; R M Bernstein; P J Holt; R S Pumphrey
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

7.  Cell surface phenotypes of radiolabeled immune long-lived lymphocytes that selectively localize in syngeneic tumours.

Authors:  J J Mulé; I Hellström; K E Hellström
Journal:  Am J Pathol       Date:  1982-05       Impact factor: 4.307

8.  Monoclonal antibody investigation in rheumatoid arthritis: presence of a T cell subpopulation bearing a double marker.

Authors:  G Lapadula; M Covelli; R Numo; G Tricarico; G Amendoni; C Berlingerio
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

9.  Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes.

Authors:  Vily Panoutsakopoulou; Katharina M Huster; Nami McCarty; Evan Feinberg; Rijian Wang; Kai W Wucherpfennig; Harvey Cantor
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

10.  Direct evidence for loss of human suppressor cells during active autoimmune disease.

Authors:  A J Strelkauskas; R T Callery; J McDowell; Y Borel; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.